
Sign up to save your podcasts
Or
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
4.3
690690 ratings
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
1,642 Listeners
4,330 Listeners
1,744 Listeners
8,648 Listeners
3,469 Listeners
111,165 Listeners
55,956 Listeners
2,235 Listeners
5,421 Listeners
5,920 Listeners
2,953 Listeners
2,021 Listeners
15,281 Listeners
4,368 Listeners
154 Listeners
1,150 Listeners
400 Listeners